Jubilant Therapeutics appoints Luca Rastelli as Chief Scientific Officer
Dr Rastelli will lead all aspects of R&D for Jubilant Therapeutics and serve as a scientific liaison for the company to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Jubilant Therapeutics
Jubilant Therapeutics, The Wistar Institute to collaborate on COVID-19 research
To evaluate the activity of novel PAD4 inhibitors to reduce clinical severity of COVID-19